LINZAGOLIX MAY ADDRESS THE LONG-TERM TREATMENT NEEDS OF WOMEN WITH UTERINE FIBROIDS (UF) WHO HAVE CONTRAINDICATIONS TO HORMONAL ADD-BACK THERAPY (ABT): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS

Authors
Category Primary study
JournalFertility and Sterility
Year 2020
This article has no abstract
Epistemonikos ID: 49cbaba59273e848307031b64b88ae13d653cff5
First added on: Feb 12, 2025